EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.14.15.15 | 25/26-hydroxycholesterol 7alpha-hydroxylase deficiency |
18577977 |
Mechanisms of disease: Inborn errors of bile acid synthesis. |
causal interaction diagnostic usage ongoing research unassigned |
4 2 3 0 |
1.14.15.15 | Adenocarcinoma |
12745462 |
An autopsy case of gallbladder cancer developing in a Japanese man with cerebrotendinous xanthomatosis: genetic analysis of the sterol 27-hydroxylase and p53 genes. |
causal interaction diagnostic usage ongoing research unassigned |
3 1 1 0 |
1.14.15.15 | Adenoma |
11167933 |
Expression of CYP27A, a gene encoding a vitamin D-25 hydroxylase in human liver and kidney. |
causal interaction ongoing research therapeutic application unassigned |
4 3 1 0 |
1.14.15.15 | alpha-methylacyl-coa racemase deficiency |
18577977 |
Mechanisms of disease: Inborn errors of bile acid synthesis. |
causal interaction diagnostic usage ongoing research unassigned |
4 2 3 0 |
1.14.15.15 | Ataxia |
7824882 |
Inborn errors of metabolism with consequences for bile acid biosynthesis. A minireview. |
causal interaction therapeutic application unassigned |
4 1 0 |
1.14.15.15 | Atherosclerosis |
8001744 |
Bile acid synthesis from cholesterol: regulatory and auxiliary pathways. |
causal interaction unassigned |
1 0 |
1.14.15.15 | Atherosclerosis |
8014582 |
Molecular genetics of cerebrotendinous xanthomatosis in Jews of north African origin. |
causal interaction unassigned |
3 0 |
1.14.15.15 | Atherosclerosis |
8078928 |
Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. |
causal interaction ongoing research unassigned |
4 4 0 |
1.14.15.15 | Atherosclerosis |
9460081 |
Competitive inhibition of hepatic sterol 27-hydroxylase by sitosterol: decreased activity in sitosterolemia. |
causal interaction ongoing research unassigned |
3 1 0 |
1.14.15.15 | Atherosclerosis |
11166758 |
A potential role for sterol 27-hydroxylase in atherogenesis. |
causal interaction therapeutic application unassigned |
4 4 0 |